Scipher Medicine
Homepage
Boston, United States · Founded 2015 · $197.8M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- sciphermedicine.com
- Total Funding
- $197.8M
- Last Round
- $5.8M Series DJul 2024
- Rounds
- 5
About
Scipher Medicine is a precision immunology company that uses AI and clinico-genomic network biology to match autoimmune patients with their most effective therapies. Its flagship product PrismRA predicts treatment response in rheumatoid arthritis, with expanding applications across autoimmune diseases.
Summary
Scipher Medicine is an Artificial Intelligence company based in Boston, United States, founded in 2015. It has raised $197.8M in total across 5 rounds, most recently a $5.8M Series D round in Jul 2024. Investors include Northpond Ventures, Khosla Ventures and Cowen Healthcare Investments.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jul 2024
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company